| Name | N-[[4-[(2S,3R)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]phenyl]methyl]-N'-[(2R,3S,4R,5S)-2,3,4,5,6-pentahydroxyhexyl]dodecanediamide |
|---|---|
| Synonyms |
Canosimiba
UNII-2GG0K1I5CI Canosimibe Canosimibum |
| Description | Canosimibe is a cholesterol absorption inhibitor extracted from patent WO2004087655A1. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C44H60FN3O10 |
|---|---|
| Molecular Weight | 809.96000 |
| Exact Mass | 809.42600 |
| PSA | 216.10000 |
| LogP | 5.86710 |